<DOC>
	<DOC>NCT00371670</DOC>
	<brief_summary>This study will test efficacy and safety of AAE581 compared to placebo in limiting cartilage loss in patients with painful knee osteoarthritis which is confirmed by X-ray</brief_summary>
	<brief_title>Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>At least one knee with osteoarthritis with KellgrenLawrence grade 3 Significant osteoarthritis pain in the knee Presence of at least one of the risk factors: obesity (BMI &gt; 28), osteoarthritis at other sites, knee effusion, family history of total joint replacement Women with childbearing potential Secondary osteoarthritis Treatment with intraarticular or systemic steroids Inability to undergo MRI acquisition Other protocol defined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Knee, osteoarthritis, pain, disease modifying</keyword>
</DOC>